John Paulson Trevena Inc Transaction History

Paulson & Co. Inc.

  • $1.47 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2017

Nov 14, 2017
SELL
$2.22 - $2.79 $904,929 - $1.14 Million
-407,626 Closed
0 $0
Q2 2017

Sep 20, 2017
BUY
N/A
407,626
407,626 $938,000

About TREVENA INC

TRVN Quotes by TradingView
  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $313M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track John Paulson's Portfolio

Track John Paulson Portfolio

Follow John Paulson (Paulson & Co. Inc.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paulson & Co. Inc., based on Form 13F filings with the SEC.

News

Stay updated on Paulson & Co. Inc. and John Paulson with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email